A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)

RECRUITING

Beijing Youan Hospital, Capital Medical University -No differernce with previous /ID# 261928, Beijing

RECRUITING

Liaoning Cancer Hospital & Institute /ID# 268023, Shenyang

RECRUITING

Harbin Medical University Cancer Hospital /Id# 262070, Harbin

RECRUITING

Zhongshan Hospital Fudan University /ID# 262135, Shanghai

RECRUITING

Zhejiang Cancer hospital /ID# 262046, Hangzhou

RECRUITING

The Second Affiliated Hospital of Nanchang University /ID# 262085, Nanchang

RECRUITING

Mengchao Hepatobiliary Hospital of Fujian Medical University /ID# 262443, Fuzhou

RECRUITING

Hubei Cancer Hospital /ID# 262030, Wuhan

RECRUITING

Henan Cancer Hospital /ID# 262098, Zhengzhou

RECRUITING

Sun Yat-Sen University Cancer Center /ID# 262092, Guangzhou

RECRUITING

Nanfang Hospital of Southern Medical University /ID# 262091, Guangzhou